Hit compounds from in silico screening for inhibitors of the EGFR dimerization process were evaluated for their anti-proliferative (CCD-1106 keratinocytes) and anti-oxidant (TBA assay) activity and their effect on EGFR dimerization (BS3 chemical crosslinking assay). 7-Benzyl-8- {N′-[1-(3-ethoxy-4-hydroxyphenyl) meth-(Z)-ylidene] hydrazino}-1, 3-dimethylxanthine 2a (127μM) leads to 37% inhibition of p-EGFR dimerization in the CCD-1106 cell line and ...